Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Caglayan, Geredeli"'
Autor:
Abdullah Sakin, Suleyman Sahin, Ayşegül Sakin, Muhammed Mustafa Atcı, Serdar Arıcı, Nurgul Yasar, Cumhur Demir, Caglayan Geredeli, Şener Cihan
Publikováno v:
İstanbul Kuzey Klinikleri, Vol 7, Iss 5, Pp 487-493 (2020)
OBJECTIVE: This study aims to investigate the factors affecting survival in operated pancreatic ductal adenocarcinoma (PDAC) and the possible prognostic effect of primary tumor localization on treatment outcomes. METHODS: In this study, 98 patients w
Externí odkaz:
https://doaj.org/article/24275e47bcdc4e1aa743fb8955e573c5
Autor:
Abdullah Sakin, Yonca Yilmaz Urun, Suleyman Sahin, Muhammed Mustafa Atici, Serdar Arici, Caglayan Geredeli, Nurgul Yasar, Cumhur Demir, Sener Cihan
Publikováno v:
İstanbul Kuzey Klinikleri, Vol 7, Iss 3, Pp 267-274 (2020)
OBJECTIVE: Squamous cell esophageal cancer (ESCC) is a highly fatal malignancy. This study aims to investigate the factors affecting survival in patients with metastatic and non-metastatic ESCC. METHODS: Between 2008 and 2016, 107 patients with ESCC
Externí odkaz:
https://doaj.org/article/f3017bc32f054c85b6e2c3c9b423e7c0
Autor:
Mustafa Karaagac, Mehmet Artac, Caglayan Geredeli, Melek Karakurt Eryilmaz, Mahmut Selman Yildirim, Tuba Akkuloglu, Ali Inal, Abdurrahman Isikdogan, Hakan Bozcuk, Ahmet Demirkazik
Publikováno v:
Medicine Science, Vol 9, Iss 1, Pp 255-60 (2020)
Results from studies in several cancers on single nucleotide polymorphisms (SNPs) suggest that DNA repair capacity may have prognostic implication for disease recurrence, survival, and responses to treatment. This study aimed to evaluate the potentia
Externí odkaz:
https://doaj.org/article/4f9cba6494ec43678eddb650bbf753de
Autor:
Abdullah Sakin, Suleyman Sahin, Muhammed Mustafa atci, Cumhur Demir, Nurgul Yasar, Caglayan Geredeli, Sener Cihan
Publikováno v:
Journal of Oncological Sciences, Vol 5, Iss 3, Pp 85-89 (2019)
Aim: The aim of this study was to evaluate the efficacy and tolerability of single-agent gemcitabine vs. capecitabine therapy in the second-line setting for metastatic Pancreatic Cancer (mPC) patients with poor performance status. Material and method
Externí odkaz:
https://doaj.org/article/78c8de41d70346d49662f865b955c5e8
Autor:
Caglayan Geredeli, Nurgul Yasar
Publikováno v:
World Journal of Surgical Oncology, Vol 16, Iss 1, Pp 1-7 (2018)
Abstract Background The aim of this study was to investigate the efficacy and safety of first-line panitumumab plus folinic acid, 5-fluorouracil and irinotecan (FOLFIRI) in patients with wild-type KRAS and wild-type NRAS metastatic colorectal cancer
Externí odkaz:
https://doaj.org/article/62d88944021b468f8fbfbbd99f97b5f0
Autor:
Hanny Al-Samkari, Caglayan Geredeli, Cagatay Arslan, Ippokratis Korantzis, Gamze Gokoz Dogu, Marina Nechaeva, Mercedes Salgado Fernandez, Beatriz Gonzalez Astorga, Valeriy Yordanov, Tudor-eliade Ciuleanu, Charles Bowers, Armando Armas, Florian Scotte, Johnny Camargo, César Muñoz, Paul Bunn, David J. Kuter, Gerald A. Soff
Publikováno v:
Blood. 140:11250-11252
Publikováno v:
International Journal of Breast Cancer, Vol 2019 (2019)
Background. The guidelines recommend considering the BRCA1 and BRCA2 germline mutations in female patients with breast carcinomas. In this retrospective study, the BRCA1/2 mutation prevalence in high-risk breast carcinoma patients in a Turkish popula
Externí odkaz:
https://doaj.org/article/157477aae8154c3e8d342b91a0641ad8
Autor:
Sabin Goktas Aydin, Burcin Cakan Demirel, Ahmet Bilici, Atakan Topcu, Musa Barış Aykan, Seda Kahraman, Ilgın Akbıyık, Muhammed Mustafa Atci, Omer Fatih Olmez, Arzu Yaren, Mehmet Ali Nahit Sendur, Caglayan Geredeli, Mesut Seker, Yuksel Urun, Nuri Karadurmus, Ahmet Aydin
Publikováno v:
Current medical research and opinion. 38(10)
Objectives: Advanced-stage biliary tract cancers (BTC) are rare malignancies with poor prognosis. There are few prospective trials, but several retrospective studies regarding treatment options. In this study, we aimed to investigate the role of syst
Autor:
Jamshid Hamdard, Abdullah Sakin, Serdar Arici, Ahmet Bilici, Tuba Saydam, Sener Cihan, Ruhper Cekin, Emin Kose, Selma Sengiz Erhan, Caglayan Geredeli, Burcu Saka, Muhammed Mustafa Atci
Publikováno v:
Colorectal Disease. 23:206-212
Aim The aim was to investigate theRASdiscordance between initial and recurrent metastasectomy specimens in metastatic colorectal cancer (mCRC) patients treated with chemotherapy (CT) plus biological agents in a first-line setting. Methods Patients wh
Autor:
Yusuf Ilhan, Ali Murat Tatli, Fatih Teker, Arif Hakan Onder, Fatih Kose, Caglayan Geredeli, Mustafa Karaagac, Muhammet Ali Kaplan, Mevlude Inanc, Sabin Goktas Aydin, Aysegul Kargi, Hacı Arak, Banu Ozturk, Ali Ayberk Besen, Oguzhan Selvi, Mustafa Korkmaz, Zeynep Oruc, Oktay Bozkurt, Ahmet Bilici, Selami Bayram, Shute Ailia Dae, Mustafa Ozdogan, Hasan Senol Coskun, Sema Sezgin Goksu
ObjectiveCisplatin-paclitaxel and bevacizumab is a frequently used treatment regimen for metastatic or recurrent cervical cancer, and carboplatin-paclitaxel and bevacizumab are also among the recommended regimens. In this study we aimed to evaluate t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7a43bb00c7770acf17bbd73232c4c59
https://hdl.handle.net/20.500.12511/9393
https://hdl.handle.net/20.500.12511/9393